Clinical Chemistry
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Clinical Chemistry 41: 1164-1170, 1995;
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Riedel, B.
Right arrow Articles by Svardal, A. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Riedel, B.
Right arrow Articles by Svardal, A. M.

Clinical Chemistry, Vol 41, 1164-1170, Copyright © 1995 by American Association for Clinical Chemistry

Fully automated assay for cobalamin-dependent methylmalonyl CoA mutase

B Riedel, PM Ueland and AM Svardal
Department of Clinical Biology, Armauer Hansens Hus, University of Bergen, Norway.

We constructed a fully automated assay for the cobalamin-dependent enzyme methylmalonyl coenzyme A (CoA) mutase. The assay involves preincubation of the enzyme with adenosylcobalamin, incubation with substrate, termination of the reaction by adding trichloroacetic acid, filtration to remove precipitated protein, and finally analysis of the filtrate (containing methylmalonyl CoA and the product succinyl CoA) by HPLC. These steps were carried out by an inexpensive programmable autosampler equipped with thermostated sample racks and mobile disposable extraction column racks used here as a sample filtering device. A central element in the developmental work was to measure stability of reagents, enzyme, and product against the storage conditions during unattended analysis and the time table of the program. We evaluated the performance of the method by measuring methylmalonyl CoA mutase activity in rat liver, human fibroblasts, and human glioma cells. The within-run imprecisions (CV) were 2-10% for measuring enzyme activity in 20 replicate samples of a homogenate (test of the automated assay), and 7-12% for measuring enzyme activity in homogenates from 20 culture dishes (test of the total procedure). The method allows the unattended analysis of 56 samples per 24 h. This strategy for automation may be easily adapted for other enzyme assays.


The following articles in journals at HighWire Press have cited this article:


Home page
 J. Biol. Chem.Home page
A. Kambo, V. S. Sharma, D. E. Casteel, V. L. Woods Jr., R. B. Pilz, and G. R. Boss
Nitric Oxide Inhibits Mammalian Methylmalonyl-CoA Mutase
J. Biol. Chem., March 18, 2005; 280(11): 10073 - 10082.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
T. Fiskerstrand, B. Riedel, P. M. Ueland, B. Seetharam, E. H. Pezacka, S. Gulati, S. Bose, R. Banerjee, R. K. Berge, and H. Refsum
Disruption of a Regulatory System Involving Cobalamin Distribution and Function in a Methionine-dependent Human Glioma Cell Line
J. Biol. Chem., August 7, 1998; 273(32): 20180 - 20184.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1995 by the American Association for Clinical Chemistry.